PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment

Stock Information for MDB Capital Holdings LLC

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MDB Capital Holdings LLC

Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter
PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork
PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services
MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time
PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
MDB Capital Holdings Announces Transitions In Its Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.